The titled “Global Antipsychotic Drugs Market” report disclosed by Orbis Research gives the Strategic Overview of the Antipsychotic Drugs industry growth and provides a path to take a proper decision for better business opportunities.
The global Antipsychotic Drugs Market was estimated at approximately REDACTED in 2017. The market is forecast to grow at a compound annual growth rate (CAGR) of REDACTED to reach approximately REDACTED by 2023. The global market is segmented based on the drug’s mechanism of action, disease indication and region.
Get Sample Pages @ http://www.orbisresearch.com/contacts/request-sample/2326203
Among the mechanism of action segments, D2 partial agonists are expected to grow at the industry’s highest rate, owing to innovative drug formulations, the protection of multiple patents on the drugs and the strong product pipelines of key players. The market for D2 antagonists is anticipated to show declining growth rates due to the severe side effects associated with the drugs and the high rate of discontinuation and withdrawal of these drugs from the market.
Antipsychotic Drugs Market Scope of Report
This report provides a detailed description of the market for antipsychotic drugs. The report highlights the current and future market potential of antipsychotic drugs and provides a detailed analysis of the competitive environment, regulatory scenario, technological advancements, patent analysis, pipeline analysis, drivers, restraints, opportunities and trends in the market. The report also covers market projections through 2023, as well as market shares for key market players. The report segments the market for antipsychotic drugs based on mechanism of action, disease indication and geography. Based on mechanism of action, the market is segmented into D2 antagonists, D2/5HT2A antagonists and D2 partial agonists. The market size includes both branded and generic drugs. Based on disease indication, the market is segmented into schizophrenia, bipolar disorder, major depressive disorder (MDD), and other diseases including anxiety, autism and dementia. By geography, the market has been segmented into the North America, Europe, Asia-Pacific, South America, and Middle East and Africa regions. The North America region includes the U.S., Canada and Mexico. Europe includes Germany, the U.K., France, Italy, Spain and the rest of Europe. Asia-Pacific includes China, India, Japan and the rest of Asia-Pacific. For market estimates, data has been provided for 2017 as the base year, with forecasts for 2018 through 2023.
Reasons for Doing Antipsychotic Drugs Market Study
Antipsychotic drugs were one of the largest classes of pharmaceutical drugs sold in the U.S. in 2010. A period of dynamic change in the market for antipsychotic drugs occurred during the period 2011 to 2016, when patents expired for major blockbuster drugs and the market began to experience the emergence of low-cost generic drugs. At the same time, several unique and innovative formulations of antipsychotic drugs were launched onto the market. New approaches for the treatment of psychosisrelated indications were pursued by pharmaceutical companies, as many of them looked beyond firstand second-generation antipsychotic drugs. These new antipsychotic drugs, with novel mechanisms of action or improved delivery systems, will provide powerful new alternatives for currently prescribed antipsychotic drugs..
Antipsychotic Drugs Market Report Includes:
- 22 data tables and 36 additional tables
- An overview of the global market for antipsychotic drugs
- Analyses of global market trends, with data from 2017, estimates for 2018 and projections of CAGRs through 2023
- Country specific data and analysis for United States, Canada, Mexico, UK, France, Germany, Italy, Spain, China, India and Japan
- Definition, history and types of antipsychotic drugs
- An understanding on receptor target of antipsychotic drugs, including dopamine, serotonin, glutamate, tachykinin and glucocorticoid
- Coverage of various psychotic diseases and their indication including schizophrenia, bipolar disorder, major depressive disorder (MDD), anxiety, autism and dementia
- Comprehensive company profiles of key players in the market, including Alexza Pharmaceuticals, Dr. Reddy's Laboratories, Ltd., Eli Lilly and Co., Johnson & Johnson, Teva Pharmaceutical Industries, Ltd., and Zydus Pharmaceuticals (USA), Inc.
Browse Full Report @ http://www.orbisresearch.com/reports/index/antipsychotic-drugs-technologies-and-global-markets
Companies Mentioned in Antipsychotic Drugs Market
- ACADIA PHARMACEUTICALS, INC.
- ALEMBIC PHARMACEUTICALS, LTD.
- ALEXZA PHARMACEUTICALS
- ALKERMES PLC
- ALLERGAN PLC
- APOTEX, INC.
- ASTRAZENECA PLC
- AUROBINDO PHARMA
- REDDY'S LABORATORIES LTD.
- ELI LILLY AND CO.
- GEDEON RICHTER PLC
- LUNDBECK A/S
- JOHNSON & JOHNSON
- LANNETT CO., INC.
- LUPIN, LTD.
- MAYNE PHARMA, INC.
- MYLAN NV
- OTSUKA HOLDINGS CO., LTD.
- SUMITOMO DAINIPPON PHARMA CO., LTD.
- SUN PHARMACEUTICAL INDUSTRIES LIMITED (SUN PHARMA)
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- TORRENT PHARMACEUTICALS, LTD.
- VANDA PHARMACEUTICALS, INC
- WOCKHARDT
- ZYDUS PHARMACEUTICALS (USA), INC.
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Contact Information:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019
Email: [email protected]
Antipsychotic Drugs Market Research Report: Information by Generation (First Generation, Second Generation), Types of Antipsychotics (Atypical Antipsychotics, Miscellaneous Antipsychotics Agents), Therapeutic Applications(Schizophrenia, Anxiety, Bipolar Disorder) and Region (the Americas, Europe, Asia-Pacific, and the Middle East & Africa) - Forecast till 2027Psychosis is a collective term used to cover are a group of disorders that are regarding the serious distortion of behavior, thought, recognition of reality, and perception.
A new report on the global antipsychotic drugs market, published by Market Research Future (MRFR), assays that this market can touch success at 4.3% CAGR between 2017 and 2022.
In terms of money value, the market can be worth USD 18.5 Bn by the end of the forecast period.
Increasing the focus of governments and health care organizations on mental health is also boosting the market.
However, some factors that can hinder the global antipsychotic drugs market growth include social stigma faced by patients, poor drug development pipeline, and a strict regulatory framework.
MRFR’s take on the market surveys various facets of the market in-depth.The generations-based segmentation of this market covers the first generation, second generation, and third generation.
Market Analysis The global antipsychotic drugs market is touted to touch USD 18.5 billion at a staggering 5.7% CAGR over the predicted years (2021-2027).
Due of lack of insight, the person is unaware that he/she is acting and thinking strangely.
These drugs are used to treat common psychotic disorders including bipolar disorder, delusions, hallucinations, schizophrenia and others.Get Request Free Sample @ https://www.marketresearchfuture.com/sample_request/2784There are many factors that is driving the growth of the antipsychotic drugs market.
Some of these factors as per the Market Research Future (MRFR) report include increasing number of people suffering from schizophrenia, increasing prevalence of psychotic disorders, over prescription of antipsychotic drugs, increased drug abuse, antipsychotic drug addiction, and huge funds being invested on R activities, and introduction of novel antipsychotic compounds.
The antipsychotic drugs market report highlights crucial details about organizations operating across North America, Europe, Asia-Pacific (APAC), and the rest of the world regional markets.
This open-label research tested the short-term efficacy and resistance of lumateperone, which was modified from prior antipsychosis of external patients who had healthy schizophhrenia.Key Players Leading players profiled in the antipsychotic drugs market include Johnson & Johnson, GlaxoSmithKline plc, AstraZeneca, Pfizer Inc., Bristol-Myers Squibb, Eli Lilly & Co. and others.
